Literature DB >> 24557669

Experimental study on the establishment and maintenance of brain death model with pigs.

Shuijun Zhang1, Jihua Shi, Wenlong Zhai, Yan Song, Shi Chen.   

Abstract

It remains controversial that after the transplantation of using grafts from brain-dead donors, organs injury and rejection can influence the effects of transplantation. This study sought to explore methods of establishing a stable brain death (BD) model using Bama mini pigs and to maintain the brain-dead state for a comparatively long period to provide a model for investigating changes in brain death. Sixteen anesthetized Bama mini pigs were randomized into a control group (n = 5) and a BD group (n = 11). Intracranial pressure (ICP) was increased in a modified, slow, and intermittent way to establish BD. Respiration and circulation were sustained during the brain-dead state. Hemodynamic changes were monitored during the experiment. In the BD group, 10 pigs met the requirements for brain death and 1 died of cardiopulmonary complications following an increase in ICP. Brain death was maintained for more than 48 hours with artificial life support. During the experiment, the heart rate and blood pressure showed characteristic changes due to increased ICP. Prior to BD being established, a "tic reaction" inevitably occurred. We used an improved method of increasing ICP to establish a stable BD model. The BD state could be maintained for more than 48 hours with effective respiratory and circulatory support. Disappearance of the tic reaction was considered to be one of the verified indexes for BD via encephalic pressure increase.

Entities:  

Year:  2007        PMID: 24557669     DOI: 10.1007/s11684-007-0030-6

Source DB:  PubMed          Journal:  Front Med China        ISSN: 1673-7342


  14 in total

Review 1.  The diagnosis of brain death.

Authors:  E F Wijdicks
Journal:  N Engl J Med       Date:  2001-04-19       Impact factor: 91.245

2.  A model of gradual onset brain death for transplant-associated studies in rats.

Authors:  J Pratschke; M J Wilhelm; M Kusaka; I Laskowski; N L Tilney
Journal:  Transplantation       Date:  2000-02-15       Impact factor: 4.939

Review 3.  Chronic rejection of organ allografts: magnitude of the problem.

Authors:  L C Paul
Journal:  Transplant Proc       Date:  1993-04       Impact factor: 1.066

4.  Survival after cardiac transplantation.

Authors:  R P Lanza; D K Cooper; D Novitzky; C N Barnard
Journal:  S Afr Med J       Date:  1983-12-17

5.  Protective effects of glycine pretreatment on brain-death donor liver.

Authors:  Shui-Jun Zhang; Ji-Hua Shi; Zhe Tang; Yang Wu; Shi Chen
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2005-02

6.  Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat.

Authors:  J A van Der Hoeven; G J Ter Horst; G Molema; P de Vos; A R Girbes; F Postema; R L Freund; J Wiersema; R van Schilfgaarde; R J Ploeg
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

7.  Effects of brain death and glucose infusion on hepatic glycogen and blood hormones in the pig.

Authors:  K Roelsgaard; H E Botker; H Stodkilde-Jorgensen; F Andreasen; S L Jensen; S Keiding
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

Review 8.  Donor treatment after pronouncement of brain death: a neglected intensive care problem.

Authors:  R M Wijnen; C J van der Linden
Journal:  Transpl Int       Date:  1991-09       Impact factor: 3.782

9.  Hepatic tolerance to hypotension as assessed by the changes in arterial ketone body ratio in the state of brain death.

Authors:  H Lin; R Okamoto; Y Yamamoto; A Maki; J Ueda; Y Tokunaga; S Yamamoto; K Mori; K Tanaka; Y Yamaoka
Journal:  Transplantation       Date:  1989-03       Impact factor: 4.939

10.  Vasopressin supplementation in a porcine model of brain-dead potential organ donors.

Authors:  E M Blaine; R D Tallman; D Frolicher; M A Jordan; L L Bluth; M B Howie
Journal:  Transplantation       Date:  1984-11       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.